FindTrial
Sign In

Which is better in opioid titration for cancer pain, oral or injection? A systematice review.

Which is better in opioid titration for cancer pain, oral or injection? A systematice review. - Which is better in opioid titration for cancer pain, oral or injection? A systematice review.

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000054161
Enrollment
500
Registered
2024-04-16
Start date
2024-04-16
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer pain

Interventions

None listed

Sponsors

The university of Tokyo
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adult cancer patients who receive or begin to receive opioids for relieving cancer pain.

Exclusion criteria

Exclusion criteria: Patients whose pain mainly result from cancer treatment or associated diseases other than cancer.

Design outcomes

Primary

MeasureTime frame
Duration until achievement of alliviating cancer pain—

Secondary

MeasureTime frame
adverse effects, QOL—

Countries

Japan,Asia(except Japan),North America,South America,Australia,Europe,Africa

Contacts

Public ContactNatsuk Nakagawa

The University of Tokyo Hospital Department of pulmonary medicine

nnakagawautmedsle@yahoo.co.jp0338155411

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026